Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial - Inagaki, N; Takeuchi, M; Oura, T (Lancet Diabetes Endocrinol, 2022)
et al.